Positions
- Chair
-
Molecular and Human Genetics
糖心视频 of Medicine
- Robert and Janice McNair Endowed Chair and Professor
-
Molecular and Human Genetics
糖心视频 of Medicine
Houston, TX, US
- Member
-
Development, Disease Models & Therapeutics Graduate Program
糖心视频 of Medicine
- Member
-
Genetics and Genomics Graduate Program
糖心视频 of Medicine
- Director
-
Center for Skeletal Medicine and Biology
糖心视频 of Medicine
- Director
-
Skeletal Dysplasia Clinic
Texas Children's Hospital
- Associate Director
-
Medical Research Pathway
糖心视频 of Medicine
- Co-Director
-
Rolanette and Berdon Lawrence Bone Disease Program of Texas
糖心视频 of Medicine
- Member
-
Dan L Duncan Comprehensive Cancer Center
糖心视频 of Medicine
Houston, Texas, United States
- Professor
-
Molecular and Human Genetics
糖心视频 of Medicine
Addresses
- Skeletal Dysplasia Center (Clinic)
-
Texas Children's Clinical Care Center
6701 Fannin St., 16th Floor
Houston, TX, 77030
United States
Phone: (832) 822-4298
Education
- BS from City University Of New York, Brooklyn College
- 06/1986 - Brooklyn, NY, United States
- PhD from State University Of New York Downstate Medical Center
- 06/1990 - Brooklyn, NY, United States
- MD from State University Of New York Downstate Medical Center
- 06/1993 - Brooklyn, NY, United States
- Residency at 糖心视频 Of Medicine
- 06/1995 - Houston, TX, United States
- Pediatrics
- Clinical Fellowship at 糖心视频 Of Medicine
- 06/1997 - Houston, TX, United States
- Clinical Genetics
- Clinical Fellowship at 糖心视频 of Medicine
- 06/1998 - Houston, Texas, United States
- Clinical Biochemical Genetics
- Post-Doctoral Fellowship at Mount Sinai School of Medicine
- 01/1991 - New York, New York, United States
Certifications
- Clinical Biochemical Genetics
- American Board of Medical Genetics
- Clinical Genetics
- American Board of Medical Genetics
- General Pediatrics
- American Board of Pediatrics
Honors & Awards
- William F. Neuman Award for Outstanding Scientific, Training, Research, and Administrative Contributions
- 2022
- American Society for Bone and Mineral Research
- Curt Stern Award for Outstanding Scientific Achievement
- 2016
- American Society for Human Genetics
- Fellow AAAS
- 2014
- American Association for the Advancement of Science
- National Academy of Medicine
- 2013
- Investigator
- Howard Hughes Medical Institute (10/2002 - 10/2014)
- Association of American Physicians
- 2010
- E. Mead Johnson Award for 鈥淥utstanding Scientific Achievement in Pediatrics鈥
- 2009
- American Society for Clinical Investigation
- 2008
- Edith and Peter O'Donnell Award in Medicine
- 2009
- Texas Academy of Medicine, Science and Engineering
- Michael E. DeBakey Excellence in Research Award
- 2007
- American Philosophical Society鈥檚 Judson Darland Prize for Achievement in Patient-Oriented Clinical Research
- 2005
- Society for Pediatric Research Young Investigator Award
- 2000
Professional Interests
- Developmental, translational and clinical studies of skeletal dysplasias and inborn errors of metabolism
Professional Statement
As a pediatrician and geneticist, the overall mission of my research program is to translate the study of structural birth defects and inborn errors of metabolism into a basic understanding of development, disease and novel therapeutic approaches. In the area of metabolism, we have applied genetic approaches to the study of biochemical genetic disorders (specifically urea cycle disorders) as models of complex diseases (those involving nitric oxide dysregulation). This has led us to study the consequences of metabolic derangements broadly in the endocrine, cardiovascular, skeletal, renal and neurological systems. In the area of structural birth defects, we have studied paracrine and endocrine signaling pathways that regulate skeletal development including morphogens (TGF飦, Wnt and Notch), and extracellular matrix proteins and their modifications (e.g., collagen prolyl-hydroxylation and lysyl-hydroxylation) that contribute to human skeletal dysplasias including brittle bone diseases and connective tissue diseases like Ehlers-Danlos syndrome. These developmental pathways have led us to ask how their dysregulation contributes to common diseases such as osteoporosis, osteoarthritis and bone cancer.
Our mechanistic discoveries are translated via clinical research that is performed as part of the Skeletal Dysplasia Clinic and the Metabolic Disorders Clinic at Texas Children鈥檚 Hospital, respectively, and as part of the NIH Rare Diseases Clinical Research Network (RDCRN) Brittle Bone Disorders Consortium. My clinical research program began with stable isotopic measurements in urea cycle disorder patients to better assess new treatments. I have led investigator-initiated studies testing combined phenylbutyrate/arginine treatment and nitric oxide supplementation in patients with argininosuccinic aciduria and phenylbutyrate in maple syrup urine disease and industry-sponsored Phase II and III studies of the now FDA-approved ammonia scavenger glyceryl-triphenylbutyrate in urea cycle patients. In the area of skeletal dysplasias, I have studied the utility of zoledronic acid, teriparatide and anti-TGF飦 treatments in pediatric and adult osteogenesis imperfecta. Our preclinical gene therapy studies have led to a clinical trial of high-capacity adenoviral gene therapy in osteoarthritis. As an extension of these studies, I lead the RE-JOIN consortium of the NIH HEAL initiative mapping the neuronal pain mediators into the osteoarthritis joint. As part of my genomic medicine studies, I have focused on advancing the diagnosis of genetic diseases via gene discovery, multi-omic approaches to phenotyping and mechanistic studies in the NIH Undiagnosed Diseases Network. Finally, I am committed to developing a scientific workforce as part of the All of Us Evenings with Genetics Scholars Program.
Our mechanistic discoveries are translated via clinical research that is performed as part of the Skeletal Dysplasia Clinic and the Metabolic Disorders Clinic at Texas Children鈥檚 Hospital, respectively, and as part of the NIH Rare Diseases Clinical Research Network (RDCRN) Brittle Bone Disorders Consortium. My clinical research program began with stable isotopic measurements in urea cycle disorder patients to better assess new treatments. I have led investigator-initiated studies testing combined phenylbutyrate/arginine treatment and nitric oxide supplementation in patients with argininosuccinic aciduria and phenylbutyrate in maple syrup urine disease and industry-sponsored Phase II and III studies of the now FDA-approved ammonia scavenger glyceryl-triphenylbutyrate in urea cycle patients. In the area of skeletal dysplasias, I have studied the utility of zoledronic acid, teriparatide and anti-TGF飦 treatments in pediatric and adult osteogenesis imperfecta. Our preclinical gene therapy studies have led to a clinical trial of high-capacity adenoviral gene therapy in osteoarthritis. As an extension of these studies, I lead the RE-JOIN consortium of the NIH HEAL initiative mapping the neuronal pain mediators into the osteoarthritis joint. As part of my genomic medicine studies, I have focused on advancing the diagnosis of genetic diseases via gene discovery, multi-omic approaches to phenotyping and mechanistic studies in the NIH Undiagnosed Diseases Network. Finally, I am committed to developing a scientific workforce as part of the All of Us Evenings with Genetics Scholars Program.
Selected Publications
-
Ketkar S, Dai H, Burrage LC, Murdock D, Dawson B, Acosta-Herrera M, Kerick M, Martin J, Wilhelm K, Asmussen JK, Lichtarge O, Center RG, Assassi S, Mayes MD, Lee BH. " " Ann Rheum Dis. 2025 Aug ; 84 : 1363-1374.
Pubmed PMID: . -
Chen YT, Jiang MM, Leynes C, Adeyeye M, Majano CF, Ibrahim B, Polak U, Hung G, Jin Z, Lanza DG, Liao L, Dawson B, Chen-Everson Y, Ruiz OE, Gibbons RJ, Heaney JD, Bae Y, Lee BH. " " J Clin Invest. 2025 Jan ; 135 : e163587.
Pubmed PMID: . -
Marom R, Song IW, Busse EC, Washington ME, Berrier AS, (...), Lee BH. " " J Clin Invest. 2024 Jun ; 134 : e170369.
Pubmed PMID: . -
Song, I. W., Nagamani, S. C., Nguyen, D., Grafe, I., et al., Lee, B.. " " J Clin Invest.. 2022 Apr ; 132 (7) : e152571.
Pubmed PMID: .
Memberships
- American Society of Human Genetics
- Member
- Society for Pediatric Research
- Member
- American College of Medical Genetics
- Member
- American Society for Clinical Investigation
- Member
- Society for Inherited Metabolic Disease
- Member
- National Academy of Medicine
- Association of American Physicians
to edit your profile